REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Monday reported a loss of $56.6 million in its first quarter. The Redwood City, California-based ...

Shareholders appeared to be happy with Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) solid earnings report last week. Looking deeper at the numbers, we found several encouraging factors ...

Pacira BioSciences PCRX is gearing up to announce its quarterly earnings on Thursday, 2025-05-08. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

May 12, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the ...

Coherus BioSciences Inc. (CHRS) reported its Q1 2025 earnings results, revealing a flat revenue of $7.3 million, despite a 15% growth in patient demand. According to InvestingPro data, the company ...

FRAMINGHAM, Mass. (AP) — FRAMINGHAM, Mass. (AP) — Xenetic Biosciences, Inc. (XBIO) on Tuesday reported a loss of $903,000 in its first quarter. The Framingham, Massachusetts-based company said ...

"Researchers have long sought a reliable, blood-based solution to track brain-derived tau pathology," said Dr. Yuling Luo, CEO, Founder and Chairman of Alamar Biosciences. "By integrating assays for ...

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — Precision BioSciences Inc. (DTIL) on Thursday reported a loss of $20.6 million in its first quarter. On a per-share basis, the Durham, North Carolina ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...

In this article, we are going to take a look at where Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stands against other Tuesday’s best-performing stocks. The stock market ended the trading session ...